May 1, 2011
By Taina Rosa
Perus healthcare industry began 2011 with a bang. In the first two months of the year alone, three M&A transactions involving both pharmaceutical companies and drug store chains were announced.
The fragmented nature of the pharmacy chain business, the need for more drug manufacturing facilities and demand for more healthcare infrastructure such as clinics, laboratories and hospitals are all expected to contribute to increased investment in the sector.
In Peru, seven drug store chains have about 60% of the market, which indicates that there is still plenty of room for consolidation and that there are too many chains competing for customers, says
M&A activity in Peru’s healthcare industry is heating up. The expansion of state-sponsored healthcare insurance will be a major factor contributing to the sector’s growth.